Benchmark Maintains Hold Rating on Select Medical

Analysts say healthcare provider's stock price target lowered to $16.50

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Research firm Benchmark reaffirmed its "hold" rating on shares of Select Medical (NYSE:SEM), a healthcare services provider based in Mechanicsburg, Pennsylvania. Benchmark also lowered its price target on the stock from $19.00 to $16.50.

Why it matters

Select Medical operates long-term acute care hospitals and inpatient rehabilitation facilities across the United States. The company's stock performance and analyst ratings provide insight into the overall health of the specialized healthcare services industry.

The details

In its research report, Benchmark cited mixed financial results from Select Medical as the reason for maintaining the hold rating. The firm noted that while Select Medical's revenue grew 6.4% year-over-year in the most recent quarter, its earnings fell short of analyst expectations.

  • Benchmark issued its research report on Wednesday, March 4, 2026.

The players

Benchmark

A research firm that provides investment analysis and ratings on publicly traded companies.

Select Medical

A leading provider of specialized healthcare services in the United States, operating long-term acute care hospitals and inpatient rehabilitation facilities.

Got photos? Submit your photos here. ›

The takeaway

Select Medical's mixed financial performance and Benchmark's hold rating suggest the specialized healthcare services industry may be facing some headwinds, underscoring the need for investors to closely monitor trends in this sector.